News - Mayne Pharma


Current filters:

Mayne Pharma

Popular Filters

Mayne Pharma signs up deals to market Subacap in Europe


Australian drugmaker Mayne Pharma (ASX: MYX) says it has signed two marketing and distribution agreements…

DermatologicalsEuropeGlenmark PharmaceuticalsIsdinitraconazoleLicensingMarkets & MarketingMayne PharmaPharmaceuticalSubacap

Mayne Pharma makes second US acquisition, this time generic drugmaker Libertas


In a second move into the US market in less than a year, Australia's Mayne Pharma (ASX: MYX) says it…

GenericsLibertas PharmaMayne PharmaMergers & Acquisitions

Mayne Pharma to acquire Kapanol in Australia from GlaxoSmithKline for up to A$14.0 million


Australia's Mayne Pharma Group (ASX: MYX) has entered into a binding agreement to acquire Kapanol and…

Asia-PacificGlaxoSmithKlineKapanolMayne PharmaMergers & AcquisitionsNeurologicalPharmaceutical

Mayne Pharma acquires Metrics for upfront $105 million


Australia's Mayne Pharma (ASX: MYX) has entered into a binding agreement to acquire Metrics, a privately-owned,…

GenericsMarkets & MarketingMayne PharmaMetrics

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top